C4 Therapeutics Inc
NASDAQ:CCCC

Watchlist Manager
C4 Therapeutics Inc Logo
C4 Therapeutics Inc
NASDAQ:CCCC
Watchlist
Price: 4.25 USD 5.99% Market Closed
Market Cap: 300m USD
Have any thoughts about
C4 Therapeutics Inc?
Write Note

Relative Value

The Relative Value of one CCCC stock under the Base Case scenario is 1.93 USD. Compared to the current market price of 4.25 USD, C4 Therapeutics Inc is Overvalued by 55%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CCCC Relative Value
Base Case
1.93 USD
Overvaluation 55%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
35
vs Industry
32
Median 3Y
11.4
Median 5Y
9.3
Industry
7.7
Forward
7.7
vs History
vs Industry
Median 3Y
-3.7
Median 5Y
-4.3
Industry
22.7
Forward
-2.6
vs History
vs Industry
Median 3Y
-4.2
Median 5Y
-5
Industry
21.6
vs History
vs Industry
Median 3Y
-4
Median 5Y
-4.8
Industry
25.2
vs History
45
vs Industry
51
Median 3Y
1.4
Median 5Y
1.6
Industry
2.5
vs History
29
vs Industry
44
Median 3Y
3.9
Median 5Y
2.6
Industry
7.7
Forward
0.7
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9
vs History
vs Industry
28
Median 3Y
-1
Median 5Y
-0.7
Industry
4.2
Forward
-0.3
vs History
vs Industry
27
Median 3Y
-1
Median 5Y
-1.5
Industry
4.1
Forward
-0.2
vs History
vs Industry
28
Median 3Y
-1.1
Median 5Y
-1.9
Industry
5.7
vs History
vs Industry
25
Median 3Y
-1.1
Median 5Y
-1.9
Industry
3.6
vs History
43
vs Industry
56
Median 3Y
0.8
Median 5Y
1.2
Industry
4.6

Multiples Across Competitors

CCCC Competitors Multiples
C4 Therapeutics Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
C4 Therapeutics Inc
NASDAQ:CCCC
283m USD 8.9 -2.7 -0.2 -0.2
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 083 264.3 -181 004.1 -219 796.6 -217 288.5
US
Abbvie Inc
NYSE:ABBV
312.7B USD 5.6 61.5 15.3 23.6
US
Amgen Inc
NASDAQ:AMGN
158.3B USD 4.9 37.4 17.5 33.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD 10.9 -241.6 24 25.2
US
Gilead Sciences Inc
NASDAQ:GILD
112.4B USD 4 891.9 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 849.9 -472 -514.1 -500.3
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 5.9 17.8 16.2 18
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.6 -58.7 -53
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.5 -129.9 -104.5 -76.2
P/E Multiple
Earnings Growth
US
C4 Therapeutics Inc
NASDAQ:CCCC
Average P/E: 208.3
Negative Multiple: -2.7
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -181 004.1 N/A
US
Abbvie Inc
NYSE:ABBV
61.5
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -241.6
42%
US
Gilead Sciences Inc
NASDAQ:GILD
891.9
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.6 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
US
C4 Therapeutics Inc
NASDAQ:CCCC
Average EV/EBITDA: 17.2
Negative Multiple: -0.2
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 796.6 N/A
US
Abbvie Inc
NYSE:ABBV
15.3
29%
US
Amgen Inc
NASDAQ:AMGN
17.5
62%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
43%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
16%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.1 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
35%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A
EV/EBIT Multiple
EBIT Growth
US
C4 Therapeutics Inc
NASDAQ:CCCC
Average EV/EBIT: 22.5
Negative Multiple: -0.2
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 288.5 N/A
US
Abbvie Inc
NYSE:ABBV
23.6
88%
US
Amgen Inc
NASDAQ:AMGN
33.1
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -500.3 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.2 N/A

See Also

Discover More
Back to Top